Indefinite Delivery Contract SPE2DX16D9991

This federal contract IDV award, with ID SPE2DX16D9991, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a single-award indefinite delivery contract (IDC) valued at up to $499,999,999, with a period of performance through December 31, 2025.

Under this IDC, the DLA can issue firm fixed-price delivery orders for DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The contract does not have any set-aside designations, which allows DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories. The delivery orders summarized have ceiling values ranging from $10 to $7,650, covering a variety of pharmaceutical and medical supplies such as epinephrine auto-injectors, antibiotics, surgical lubricants, and multivitamins. This contract strengthens DMS Pharmaceutical Group's position as a key supplier in the federal pharmaceutical supply chain, providing both routine and specialized medications to DoD and VA healthcare sites.